These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24092506)

  • 1. Prognostic factors in neuroendocrine tumours of the lung: a single-centre experience.
    Filosso PL; Ruffini E; Di Gangi S; Guerrera F; Bora G; Ciccone G; Galassi C; Solidoro P; Lyberis P; Oliaro A; Sandri A
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):521-6; discussion 526. PubMed ID: 24092506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
    Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroendocrine tumors of the lung].
    Oliaro A; Donati G; Filosso PL; Ruffini E
    Minerva Chir; 2000; 55(1-2):7-16. PubMed ID: 10832278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
    Beasley MB; Lantuejoul S; Abbondanzo S; Chu WS; Hasleton PS; Travis WD; Brambilla E
    Hum Pathol; 2003 Feb; 34(2):136-42. PubMed ID: 12612881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors.
    Lim E; Yap YK; De Stavola BL; Nicholson AG; Goldstraw P
    J Thorac Cardiovasc Surg; 2005 Oct; 130(4):969-72. PubMed ID: 16214506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung.
    Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF
    Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung.
    García-Yuste M; Matilla JM; Cueto A; Paniagua JM; Ramos G; Cañizares MA; Muguruza I;
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):192-7. PubMed ID: 17196822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung.
    Righi L; Volante M; Rapa I; Tavaglione V; Inzani F; Pelosi G; Papotti M
    Endocr Relat Cancer; 2010 Dec; 17(4):977-87. PubMed ID: 20817788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
    Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
    Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors.
    Galván JA; Astudillo A; Vallina A; Crespo G; Folgueras MV; González MV
    BMC Cancer; 2014 Nov; 14():855. PubMed ID: 25413006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trends in prognostic factors for neuroendocrine lung tumors].
    García-Yuste M; Molins L; Matilla JM; González-Aragoneses F; López-Pujol J; Ramos G; de la Torre M;
    Arch Bronconeumol; 2007 Oct; 43(10):549-56. PubMed ID: 17939909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features.
    Faggiano A; Sabourin JC; Ducreux M; Lumbroso J; Duvillard P; Leboulleux S; Dromain C; Colao A; Schlumberger M; Baudin E
    Cancer; 2007 Jul; 110(2):265-74. PubMed ID: 17569104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids.
    Daddi N; Schiavon M; Filosso PL; Cardillo G; Ambrogi MC; De Palma A; Luzzi L; Bandiera A; Casali C; Ruffato A; De Angelis V; Andriolo LG; Guerrera F; Carleo F; Davini F; Urbani M; Mattioli S; Morandi U; Zannini P; Gotti G; Loizzi M; Puma F; Mussi A; Ricci A; Oliaro A; Rea F;
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):677-86. PubMed ID: 24099733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-appraisal of N2 disease by lymphatic drainage pattern for non-small-cell lung cancers: by terms of nodal stations, zones, chains, and a composite.
    Zheng H; Wang LM; Bao F; Jiang GN; Xie HK; Ding JA; Hu XF; Chen C
    Lung Cancer; 2011 Dec; 74(3):497-503. PubMed ID: 21529990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical mediastinal nodal removal improves disease-free survival for pulmonary low-grade malignant tumors.
    Zheng H; Xie HK; Li C; Bao F; Ding JA; Jiang GN; Zhang RX; Chen C
    Lung Cancer; 2012 Mar; 75(3):342-7. PubMed ID: 21840617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small intestinal neuroendocrine tumors: prognostic factors and survival.
    Bergestuen DS; Aabakken L; Holm K; Vatn M; Thiis-Evensen E
    Scand J Gastroenterol; 2009; 44(9):1084-91. PubMed ID: 19572232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group.
    Filosso PL; Guerrera F; Evangelista A; Welter S; Thomas P; Casado PM; Rendina EA; Venuta F; Ampollini L; Brunelli A; Stella F; Nosotti M; Raveglia F; Larocca V; Rena O; Margaritora S; Ardissone F; Travis WD; Sarkaria I; Sagan D;
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):441-7; discussion 447. PubMed ID: 25564217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary carcinoid tumours: indolent but not benign.
    De Dosso S; Bajetta E; Procopio G; Cortinovis D; Buzzoni R; Catena L; Platania M; Verzoni E
    Oncology; 2007; 73(3-4):162-8. PubMed ID: 18418008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.